Skip to content
Clinical Trials – home
Fondazione Toscana Gabriele Monasterio
Sponsor

Fondazione Toscana Gabriele Monasterio

Italy Via Trieste 41, 56126 Pisa, Italy

About the sponsor

Research activity centres on ATTR cardiac amyloidosis and AL cardiac amyloidosis, with a strong focus on PET/CT approaches for identifying cardiac amyloid deposits and distinguishing diagnostic pathways.

  • 18F-flutemetamol tracer evaluation
  • 18F-florbetaben PET/CT diagnostic assessment
  • Non-invasive diagnosis of AL-CA

The sponsor’s work in this area is directed toward improving the recognition of amyloid involvement in the heart and supporting clearer diagnostic classification across inherited and wild-type disease.

About Specializations

Fondazione Toscana Gabriele Monasterio runs clinical trials in conditions such as Cardiac amyloidosis, Atrial fibrillation, Acquired ATTR amyloidosis, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

4 clinical trials

Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Florbetaben (18F)
  • Sponsor:Fondazione Toscana Gabriele Monasterio
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Fondazione Toscana Gabriele Monasterio
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Fondazione Toscana Gabriele Monasterio
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Flutemetamol (18F)
  • Sponsor:Fondazione Toscana Gabriele Monasterio

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.